Related Experiment Video

Updated: Sep 20, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation

Maoxiang Li1, Jun-Ying Zhou, Yubin Ge

  • 1Departments of Pathology and Pharmacology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

The Journal of Biological Chemistry
|August 2, 2003
PubMed

Insights

The tumor suppressor p53 protein regulates cell growth. This study reveals p53 activates MKP1, a phosphatase, to control the cell cycle in response to MAPK signaling without DNA damage.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • The tumor suppressor p53 protein is crucial for suppressing cell growth via cell cycle arrest or apoptosis.
  • While p53's role in G1 arrest due to DNA damage is understood, its function in response to MAPK signaling is unclear.

Purpose of the Study:

  • To investigate the role of p53 in cell cycle regulation in response to MAPK signaling.
  • To identify novel mechanisms by which p53 controls cell cycle progression.

Main Methods:

  • Analysis of MKP1 (a MAPK phosphatase) as a transcriptional target of p53.
  • Assessing p53 binding to the MKP1 gene promoter and its transactivation activity.
  • Evaluating the impact of MKP1 phosphatase activity on p53-mediated G1 arrest and cell cycle re-entry.

Main Results:

  • MKP1 mRNA and protein levels increase upon p53 activation.
  • p53 directly binds to and transactivates the MKP1 gene.
  • Inhibition of MKP1 phosphatase activity impairs p53-mediated G1 arrest; MKP1 expression prevents cell cycle re-entry.

Conclusions:

  • p53 negatively regulates the MAPK pathway through MKP1.
  • This study uncovers a novel p53-dependent mechanism for cell cycle control independent of DNA damage.
  • MKP1 is a key mediator of p53's function in cell cycle arrest.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...